Representative before the EPO

Company dna patent attorney dorte klostermeyer rauber
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 46 EP applications Dörte Klostermeyer-Rauber has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12706049

3-AMINO-PYRIDINES AS GPBAR1 AGONISTS

IPC classification:
A61K 31/4433, A61K 31/4418, C07D 491/107, C07D 417/12, C07D 417/04, C07D 413/12, C07D 413/04, C07D 405/12, C07D 405/04, C07D 401/14, C07D 401/12, C07D 401/04, C07D 213/82, C07D 213/81, C07D 213/75
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12754017

3 -PYRIDINE CARBOXYLIC ACID HYDRAZIDES AS HDL-CHOLESTEROL RAISING AGENTS

IPC classification:
A61K 31/444, A61K 31/4439, A61K 31/443, A61K 31/44, C07D 417/12, C07D 413/14, C07D 413/12, C07D 405/04, C07D 401/06, C07D 213/87
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756212

5-CYCLOALKYL- OR 5-HETEROCYCLYL-NICOTINAMIDES

IPC classification:
A61K 31/4412, C07D 417/12, C07D 413/12, C07D 401/12, C07D 213/82, A61P 9/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759084

N-(5-CYCLOALKYL- OR 5-HETEROCYCLYL-)-PYRIDIN-3-YL CARBOXAMIDES

IPC classification:
A61K 31/4965, A61K 31/465, C07D 413/12, C07D 401/12, C07D 213/74, A61P 9/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12840084

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/00, A61P 27/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP12775028

1-CYCLOALKYL- OR 1-HETEROCYCLYL-HYDROXYIMINO-3-PHENYL-PROPANES

IPC classification:
A61K 31/45, A61K 31/445, A61K 31/382, A61K 31/35, A61K 31/15, C07D 335/02, C07D 309/06, C07D 211/40, C07C 317/32, C07C 251/42, A61P 3/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12784005

1-PYRIDAZINYL-HYDROXYIMINO- 3- PHENYL- PROPANES AS GPBAR1 AGONISTS

IPC classification:
A61K 31/50, C07D 237/08, A61P 3/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13746304

COMPOSITIONS AND METHODS FOR USING CSF1R INHIBITORS

IPC classification:
A61K 39/395, C07K 16/24, A61P 19/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13707658

ANTI-P-SELECTIN ANTIBODY FORMULATION

IPC classification:
A61K 47/26, A61K 47/18, A61K 47/10, A61K 9/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12802488

PCSK9-BINDING POLYPEPTIDES AND METHODS OF USE

IPC classification:
A61K 45/06, A61K 39/395, A61K 39/00, A61K 38/18, A61K 38/17, A61K 31/40, A61K 31/22, C12N 15/63, C12N 9/64, C07K 19/00, C07K 16/40, C07K 14/705, C07K 14/485, A61P 9/10, A61P 3/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713197

1,2- PYRIDAZINE, 1,6- PYRIDAZINE OR PYRIMIDINE - BENZAMIDE DERIVATIVES AS GPBAR1 MODULATORS

IPC classification:
A61K 31/505, A61K 31/50, C07D 401/04, C07D 239/42, C07D 237/20, A61P 29/00, A61P 3/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13733479

ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13802836

RON COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/395, C12N 5/10, C07K 16/28, C07K 14/52
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14776479

FORMULATIONS WITH REDUCED OXIDATION

IPC classification:
A61K 39/395, A61K 38/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11808100

ANTI-PCSK9 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14773506

FORMULATIONS WITH REDUCED OXIDATION

IPC classification:
A61K 39/395, A61K 38/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14780964

METHODS OF USING ANTI-LGR5 ANTIBODIES

IPC classification:
A61P 35/00, A61K 31/015, A61K 39/395, C07K 16/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP11797222

OXIME COMPOUNDS AS HDL-CHOLESTEROL RAISING AGENTS

IPC classification:
A61P 9/00, A61K 31/4965, A61K 31/465, C07D 241/24, C07D 213/74, C07D 213/63
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15703385

METHODS OF USING ANTI-STEAP1 ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/00, A61K 47/48
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721059

COMBINATION THERAPY COMPRISING ANTI-ANGIOGENESIS AGENTS AND OX40 BINDING AGONISTS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/22
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716335

ANTI-OX40 ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716824

4-AMINO-IMIDAZOQUINOLINE COMPOUNDS

IPC classification:
A61P 37/02, A61P 31/00, A61P 35/00, A61K 31/437, A61K 31/4188, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15720875

METHODS OF TREATING EARLY BREAST CANCER WITH TRASTUZUMAB-MCC-DM1 AND PERTUZUMAB

IPC classification:
A61K 39/00, A61K 47/50, C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15730643

ANTI-LGR5 ANTIBODIES AND USES THEREOF

IPC classification:
G01N 33/577, A61P 35/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15822079

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

IPC classification:
A61P 35/00, A61K 31/7088, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15801009

COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND TIGIT INHIBITORS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797510

ASSAYS FOR DETECTING T CELL IMMUNE SUBSETS AND METHODS OF USE THEREOF

IPC classification:
G01N 33/574, G01N 33/569
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15791886

METHODS AND BIOMARKERS FOR PREDICTING EFFICACY AND VALUATION OF AN OX40 AGONIST TREATMENT

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15802289

COMBINATION THERAPY COMPRISING OX40 BINDING AGONISTS AND PD-1 AXIS BINDING ANTAGONISTS

IPC classification:
A61K 31/337, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797922

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

IPC classification:
C07K 16/28, C12N 15/62, C07K 16/46, A61K 47/50, C07K 14/705
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16162539

TRIMERIC COSTIMULATORY TNF FAMILY LIGAND-CONTAINING ANTIGEN BINDING MOLECULES

IPC classification:
C12N 15/62, C07K 16/30, C07K 16/28, A61K 47/50, C07K 14/705
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
The application has been published
EP15821033

BENZAZEPINE SULFONAMIDE COMPOUNDS

IPC classification:
A61P 37/00, A61P 35/00, A61K 31/55, C07D 401/12, C07D 401/04, C07D 223/16, C07D 401/14, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16169237

C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES

IPC classification:
C07K 16/28, C07K 16/14, C07K 14/705, A61K 39/395, C07K 14/715, C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
The application has been published
EP16169487

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND PD1 BINDING MOIETY

IPC classification:
C12N 15/62, C07K 16/28, A61K 39/395, C07K 14/705
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
The application has been published
EP16707464

BENZAZEPINE DICARBOXAMIDE COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/55, C07D 223/16, C07D 403/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16712858

ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND

IPC classification:
C07K 16/40, C07K 16/28, C07K 14/705, A61K 39/395, A61K 38/17
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16730137

COMPOSITIONS AND METHODS FOR USING ANTI-IL-34 ANTIBODIES TO TREAT NEUROLOGICAL DISEASES

IPC classification:
C07K 16/24, A61K 45/06, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16732086

METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES

IPC classification:
A61P 35/00, A61K 39/395, C12Q 1/68, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16730181

METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16741212

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

IPC classification:
A61K 39/395, G01N 33/574, C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16763865

SULFINYLPHENYL OR SULFONIMIDOYLPHENYL BENZAZEPINES

IPC classification:
A61P 29/00, A61K 31/55, C07D 401/04, C07D 223/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16777648

BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16782349

PYRROLOBENZODIAZEPINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE

IPC classification:
C07K 16/32, C07D 519/00, C07K 16/28, C07K 16/18, C07D 487/04, A61K 47/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16774655

ANTI-HUMAN CD19 ANTIBODIES WITH HIGH AFFINITY

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16774932

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

IPC classification:
C07K 16/40, C07K 16/30, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16794157

ANTI-HTRA1 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
C07K 16/40
Applicant:
F. Hoffmann-La Roche AG
Agent:
Dörte Klostermeyer-Rauber, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature